Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

News Conference News AHA 2018

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

Yael L. Maxwell

November 12, 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

News Conference News AHA 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Michael O'Riordan

November 11, 2018

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

November 02, 2018

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

News Daily News

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

Michael O'Riordan

October 19, 2018

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

July 30, 2018

Class I Recall for Medtronic’s HeartWare HVAD System

News Daily News

Class I Recall for Medtronic’s HeartWare HVAD System

Michael O'Riordan

June 04, 2018

News Daily News

HeartMate 3 Problem With Outflow Graft Twisting Called Class I Recall by FDA

May 23, 2018

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

News Conference News ACC 2018

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

March 16, 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

News Conference News CRT 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Michael O'Riordan

March 05, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.